Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
---|
09/16/2004 | WO2004078733A1 Quinazolines useful as modulators of ion channels |
09/16/2004 | WO2004078732A1 N-aryl heteroaromatic products, compositions containing same and use thereof |
09/16/2004 | WO2004078731A1 Quinoline-carboxylic acids and the derivatives thereof, a focused library |
09/16/2004 | WO2004078729A1 Process for the production of substituted nicotinic acid esters |
09/16/2004 | WO2004078128A2 Substituted pyridine derivatives useful in the treatment of cancer and other disorders |
09/16/2004 | WO2004062562A3 Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
09/16/2004 | WO2004048544A3 Ca ix-specific inhibitors |
09/16/2004 | WO2004047837A3 Beta-blockers having antioxidant and nitric oxide-donor activity |
09/16/2004 | WO2004047730A3 Compounds for inhibition of hiv infection by blocking hiv entry |
09/16/2004 | WO2004046101A3 Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
09/16/2004 | WO2004033652A3 Inhibitors of fatty acid amide hydrolase |
09/16/2004 | WO2003104257A3 Protease inhibitors |
09/16/2004 | WO2003072553A8 N-aryl-2-oxazolidinone-5-carboxamides and their derivates and their use as antibacterials |
09/16/2004 | WO2003028729A3 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade |
09/16/2004 | US20040181067 Tri(cyclo) substituted amide compounds |
09/16/2004 | US20040181066 Tyrosine kinase inhibitors |
09/16/2004 | US20040181062 Benzimidazole cyclooxygenase-2 inhibitor |
09/16/2004 | US20040181059 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
09/16/2004 | US20040180942 modulating farnesoid X receptor (FXR), liver X receptors (LXR alpha and LXR beta ) and/or orphan nuclear receptors; treatment of lipid, cardiovascular and neurodegenerative disorders |
09/16/2004 | US20040180936 having an inhibitory activity on calpains and/or a trapping activity on reactive oxygen species; inflammatory and immunological diseases; disorders of the central or peripheral nervous system |
09/16/2004 | US20040180925 such as (S)-1-[2-(2-Pyrazinylamino)ethylamino]acetyl-2-pyrrolidinecarbonitrile dimethanesulfonate |
09/16/2004 | US20040180924 Novel heterocyclic derivatives and medicinal use thereof |
09/16/2004 | US20040180912 for promoting the release of parathyroid hormone, e.g. for preventing or treating bone conditions which are associated with increased calcium depletion or resorption or in which stimulation of bone formation and calcium fixation in the bone is desirable |
09/16/2004 | US20040180906 Anti-inflammatory medicaments |
09/16/2004 | US20040180902 3-Substituted quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists |
09/16/2004 | US20040180887 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
09/16/2004 | US20040180885 Indole derivatives, process for preparation of the same and use thereof |
09/16/2004 | US20040180878 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
09/16/2004 | US20040180877 Nicotinic acetylcholine receptor cholinergic ligands, monoamine receptor and transporter modulators; such as 1-(2-Benzo[b]thiophenyl-1,1-dioxide)-imidazolidine |
09/16/2004 | CA2517844A1 Quinazolines useful as modulators of ion channels |
09/16/2004 | CA2517708A1 5-phenylthiazole derivatives and their use as p13 kinase inhibitors |
09/16/2004 | CA2517422A1 Tetrahydropyran compounds as tachykinin antagonists |
09/16/2004 | CA2517088A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
09/16/2004 | CA2516931A1 Novel bicyclic urea derivatives useful in the treatment of cancer and other disorders |
09/16/2004 | CA2512243A1 N-aryl heteroaromatic products, compositions containing same and use thereof |
09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
09/15/2004 | EP1457488A1 Intermediates for use in the preparation of urea compounds having muscarinic receptor antagonist activity |
09/15/2004 | EP1456207A2 Heterocyclic acridone inhibitors of impdh enzyme |
09/15/2004 | EP1456203A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
09/15/2004 | EP1456202A1 Benzothiazoles |
09/15/2004 | EP1456188A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
09/15/2004 | EP1456187A1 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders, cancer, and other diseases |
09/15/2004 | EP1456180A1 3,4-diarylpyrazoles and their use in the therapy of cancer |
09/15/2004 | EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors |
09/15/2004 | EP1455792A1 Ureas of 2-aminobenzothiazoles as adenosine modulators |
09/15/2004 | EP1455785A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
09/15/2004 | EP1455777A1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders |
09/15/2004 | EP1455579A1 Pyrazoles-pyrimidine fungicides |
09/15/2004 | EP1363902B1 Chemical compounds |
09/15/2004 | EP1349849B1 Microbiocidal n-phenyl-n-[4-(4-pyridyl)-2-pyrimidin-2-yl]-amine derivatives |
09/15/2004 | EP1295878B1 Pyrazinone derivatives |
09/15/2004 | EP1254135B1 Aminoheterocyclylamides as pesticides and antiparasitic agents |
09/15/2004 | EP1196408B1 Respiratory syncytial virus replication inhibitors |
09/15/2004 | EP1185526B1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
09/15/2004 | EP1169311A4 Oxazole and thiazole combinatorial libraries |
09/15/2004 | EP0983054B1 Hair growth compositions and uses |
09/15/2004 | CN1529698A Taiazole or oxazole derivatives which are useful in treatment of cardiovascular and related diseases |
09/15/2004 | CN1529601A 四氢喹啉衍生物 Tetrahydroquinoline derivative |
09/15/2004 | CN1529596A Utilization of benzdihydro-pyrane |
09/15/2004 | CN1528761A N-tert-butyl-2 (benzothiazyl) sulfenamide and production process thereof |
09/15/2004 | CN1166665C Arylpiperidine derivatives and use thereof |
09/15/2004 | CN1166629C Benzene sulfonamide compounds, its preparing method and medicinal compsns. contg. same |
09/14/2004 | US6790957 Converting tertiary hydroxy group of a triazole antifungal compound into a phosphate group to improve aqueous solubility |
09/14/2004 | US6790864 Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group |
09/14/2004 | US6790860 Pyrrolidine derivatives |
09/14/2004 | US6790859 Therapy or reducing progression of hypertension or damage to a tissue caused by contact with elevated levels of reducing sugars in an animal, comprising administering to the animal an effective amount of thiazolium compounds |
09/14/2004 | US6790844 Muscle relaxants; antiserotonine agent |
09/10/2004 | WO2004076693A1 Tailored treatment suitable for different forms of mastocytosis |
09/10/2004 | WO2004076447A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament |
09/10/2004 | WO2004076441A1 Process for producing acid adduct salt of polyacidic base compound |
09/10/2004 | WO2004076424A1 Heterocyclic kinase inhibitors |
09/10/2004 | WO2004076421A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides |
09/10/2004 | WO2004076420A1 Heteroarylcarbamoylbenzene derivative |
09/10/2004 | WO2004076415A1 1- (hetero)aroyl-pyrrolidine-2-carboxylic acid derivatives useful as anti.viral agents |
09/10/2004 | WO2004076413A2 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism |
09/10/2004 | WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors |
09/10/2004 | WO2004075895A1 Ocular hypotensive agent |
09/10/2004 | WO2004060362A3 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β |
09/10/2004 | WO2004056832A3 Epothilone derivatives |
09/10/2004 | WO2004047769A3 Benzimidazoles and analogs thereof as antibacterials |
09/10/2004 | WO2004041776A3 SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS |
09/10/2004 | WO2003087092A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease |
09/10/2004 | CA2517308A1 Tailored treatment suitable for different forms of mastocytosis |
09/10/2004 | CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors |
09/10/2004 | CA2516657A1 Cycloalkyl derivatives comprising bioisosteric carboxylic acid groups, method for the production thereof, and use thereof as a medicament |
09/10/2004 | CA2516407A1 Heteroarylcarbamoylbenzene derivatives |
09/10/2004 | CA2515963A1 Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism |
09/09/2004 | US20040176609 Compounds used as bactericides for treatment of infections |
09/09/2004 | US20040176605 Compounds as antumor agents or immunosuppressants |
09/09/2004 | US20040176603 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
09/09/2004 | US20040176594 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
09/09/2004 | US20040176593 Cyclic diamine compounds used as drugs and chemical intermediates |
09/09/2004 | US20040176443 Capsaicin receptor ligands |
09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
09/09/2004 | US20040176432 simplified manner using considerably less process steps and with considerably improved yield and diastereoselectivity |
09/09/2004 | US20040176431 Antiproliferative 2-(sulfo-phenyl)-aminothiazole derivatives and pharmaceutical compositions, and methods for their use |
09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
09/09/2004 | US20040176427 Alpha type human peroxisome proliferator activated receptor agonists; such as 2-methyl-2-(3-methyl-4-(((4-phenoxymethyl-2-(4-trifluoromethylphenyl) -thiazol-5-yl-carbonyl)-amino)-methyl)phenoxy)propionic acid |
09/09/2004 | US20040176422 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
09/09/2004 | US20040176418 protease activated receptor (PAR) antagonists will be useful in the treatment of thrombotic, inflammatory, atherosclerotic and fibroproliferative disorders |